CRISPR reveals possible ALS drug target – FierceBiotech
FierceBiotech |
CRISPR reveals possible ALS drug target
FierceBiotech Amyotrophic lateral sclerosis (ALS) is driven by protein “aggregates,” or clumps in the brain, that make voluntary muscle movements progressively more difficult. Problem is, scientists have struggled to figure out how these toxic protein clumps cause … Potential drug targets for ALS revealed in study using CRISPR CRISPR Human Knockout Screens Identify New Target for ALS |
